ArticleMicrobiology spectrum2024

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).

Martina Frodlund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.